痰热清注射液联合头孢菌素治疗慢性支气管炎的临床疗效观察

The clinical curative effect of Tanreqing injection combined with cephalosporins for treatment of chronic bronchitis

目的探讨临床上采用痰热清注射液结合头孢菌素治疗慢性支气管炎的疗效。方法选取2013年3月~2014年3月于我院呼吸内科进行慢性支气管炎治疗的患者60例,按照随机分配的原则将其分为对照组和观察组。将采用头孢菌素对慢性支气管炎患者进行治疗的标记为对照组,其余在对照组的基础上联合痰热清注射液进行治疗的患者标记为观察组。结果对于两组患者的疗效比较,观察组的患者疗程范围内,每周的显效率和总有效率方面均明显优于对照组患者;药物的作用效果的比较上,观察组患者在起效时间和半年的跟踪临床控制率方面均明显优于对照组患者;以上各项均具有统计学意义（P〈0.05）。在不良反应比较方面,对照组和观察组患者在不良反应发生率方面相差不大,差异无统计学意义（P〉0.05）。结论痰热清注射液联合头孢菌素治疗慢性支气管炎方面因其疗效明显、起效快,值得在临床上推广使用。

Objective To observe of Tanreqing injection combined with cephalosporins for treatment of chronic bronchitis. Methods 60 cases of patients from March 2013 to March 2014 on the respiratory department of internal medicine in our hospital for treatment of chronic bronchitis were divided into the observation group and the control group according to random assignment principle. The patients with chronic bronchitis were treated with cephalosporin as control group. The others patients in the control group were treated with Tanreqing injection combined with cephalosporins.ResultsCompared to the effect of the two groups, the weekly observation show the efficiency and the total efficiency rate of observation group was significantly better than the control group patients. The onset time and half track clinical efficiency of observation group was significantly better than the control group, all of the above were statistically significant （P〈0.05）.In comparison to the adverse reaction, the control group and the observation group patients had little difference in the incidence of adverse reactions, the difference was not statistically significant （P〉0.05）.Conclusion The treatment of Tanreqing injection combined with cephalosporins for chronic bronchitis is obvious curative effect, quick effect, worthy of promotion in clinical use.